Article
The cellular and molecular heterogeneity of the aggressive non-Hodgkin's lymphomas.
Current opinion in oncology - 1 Sept 1998
Howard O M, Shipp M A
Abstract excerpt
The majority of patients with aggressive non-Hodgkin's lymphomas (NHLs) still die of their disease. Although clinical prognostic factors can be used to characterize a patient's risk profile, these clinical features are likely to be surrogate variables for the intrinsic cellular and molecular hete...
Topics
- Cell Adhesion Molecules
- Cytokines
- Endothelial Growth Factors
- Genes, Tumor Suppressor
- Genetic Heterogeneity
- Humans
- Lymphokines
- Lymphoma, Non-Hodgkin
- Metalloendopeptidases
- Mutation
- Proto-Oncogenes
- Tissue Inhibitor of Metalloproteinases
- Translocation, Genetic
- Vascular Endothelial Growth Factor A
- Vascular Endothelial Growth Factors